Match Document Document Title
5972326 Controlled release of pharmaceuticals in the anterior chamber of the eye  
The present invention relates to compositions which maintain the structural integrity of the anterior chamber of the eye during ophthalmologic surgery, thereby protecting the tissues that form and...
5968546 Keratinocyte culture from precursor cells  
The present invention relates to the treatment of skin defect by organotypically cultured autologous keratinocytes isolated from the outer root sheath of hair follicles. Methods for primary as well...
5965161 Extruded multi-particulates  
A unit dose sustained-release oral dosage form containing a plurality of melt-extruded particles, each consisting essentially of a therapeutically active agent, one or more retardants, and an...
5962520 Hydrolytically unstable, biocompatible polymer  
A hydrolytically unstable, biocompatible polymer capable of carrying and releasing a pharmaceutical compound when introduced into physiological media. In a preferred embodiment, the polymer...
5958452 Extruded orally administrable opioid formulations  
Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques are disclosed.
5955112 Non-stinging styptic pencil  
A non-stinging styptic composition in the form of a water soluble resin coated cast pencil, for stopping bleeding from cuts and nicks received during shaving. The composition comprises aluminum...
5942244 Local oral herbal slow release tablets  
A tablet for the local and slow release of herbal medication into the oral cavity of a subject. Also provided is a method of making the tablet and a method of using the tablet. The tablet includes...
5942242 Medicaments for nasal administration  
A medicament for nasal administration to be used for disease prevention or treatment comprising a vaccine or a pharmacologically active peptide compounded with an ion exchange resin or adsorbent...
5939358 Compatibility agent and method  
A compatibility agent comprising a block copolymer of ethylene oxide and propylene oxide comprising about 30-80% ethylene oxide and about 20-70% propylene oxide which has been found useful for...
5932205 Biochemical contact lens for treating photoablated corneal tissue  
Methods for treating photoablated corneal tissue are described. The methods include contacting photoablated corneal tissue with a contact lens which includes an amniotic composition such that...
5928655 Compact solid gel containing water  
A compact solid gel is described containing water, that consists of water in a concentration ranging from 15% to 90%, thermoreversible polysaccharides in a concentration ranging from 0.3% to 4%,...
5922357 Polymer microspheres and a method of production thereof  
The invention relates to microspheres which are suitable for biomedical uses which have a diameter in the range of 10 nm to 2 mm and which comprise a substantially spherical core particle of a...
5922776 Sustained release, transparent biocidal compositions  
A composition for retarding bacterial, fungal and viral contamination and mold growth containing an acid releasing polymer, a hydrophilic material, and chlorite anions. Each component of the...
5919484 Controlled release, drug-delivery tableted composition including a polymer of a vinyl amide, (meth)acrylic acid, a long chain alkyl (meth)acrylate and a lower alkyl (meth)acrylate  
A controlled release, drug-delivery tableted composition comprising, by weight, an uncrosslinked or crosslinked polymer of (a) about 5-40% of a vinyl amide, (b) about 10-70% of (meth)acrylic acid,...
5919481 Fill material for soft gelatin pharmaceutical dosage form  
The present invention relates to a substantially translucent, semi-solid fill material for a soft gelatin capsule containing a therapeutically effective amount of a pharmaceutical dissolved or...
5916584 Controlled release container with core and outer shell  
A controlled release container includes an outer shell and a separately produced core that comprises at least one bioactive molecule. At least a portion of the outer shell comprises a biodegradable...
5916590 Soft gelatin pharmaceutical dosage form  
The present invention relates to a substantially translucent, gel fill material for a soft gelatin capsule containing a therapeutically effective amount of a pharmaceutical dissolved or suspended...
5910312 Acne treatment composition with vasoconstrictor  
The acne treatment composition of the present invention includes an effective amount of acne treatment medication selected from the group consisting of benzoyl peroxide and salicylic acid, and...
5908619 Hydroalcoholic compositions thickened using surfactant/polymer complexes  
Hydroalcoholic compositions and methods of preparation are provided. The composition includes a lower alcohol and water in a weight ratio of at least about 20:80 and a thickener system comprising a...
5908636 Fill material for soft gelatin pharmaceutical dosage form containing an antiflatulent  
The present invention relates to a semi-solid fill material for a soft gelatin capsule containing a therapeutically effective amount of an antiflatulent. The semi-solid is sufficiently viscous so...
5908633 Bioartificial hormone releasing device  
A device for the effective release of hormones wherein a matrix containing a hormone producing cellular moiety is encapsulated with a non-immunogenic polymeric material of poly-para-xylyene having...
5905072 Adjuvants for systemic fungicides, fungicidal compositions which contain them and their use  
Adjuvants for systemic fungicides in the form of a stable microemulsion comprise water, a mixture of methyl esters of fatty acids obtained by the transesterification of vegetable oils, an anionic...
5902606 Solid and liquid solutions of sparingly water-soluble medicinal substances  
Sparingly water-soluble active compounds, for example medicinal substances, are converted into the dissolved (molecularly disperse) state by dissolving them in a hydrophilic peptide having a...
5902589 Method for treating hydratable polymers, compositions obtained therefrom, and methods of using same  
Aqueous solutions of hydratable polymers are prepared by hydrating a hydratable polymer in water without agitation sufficient to shear the molecular structure of the polymer thereby maintaining...
5902603 Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use  
High capacity drug reservoirs are provided for incorporation into transdermal drug delivery systems. The drug reservoirs are hydrogels formulated from polyurethanes crosslinked with diisocyanate...
5900233 Epichlorohydrin and 1-(3-aminopropyl) imidazole copolymer and its use in treating irritable bowel syndrome  
An anion-binding hydrophilic epichlorohydrin and 1-(3-aminopropyl)imidazole copolymeric bile acid sequestrant, pharmaceutical compositions thereof, and use thereof in the treatment of ailments or...
5897874 Expulsion of material from a delivery device  
A delivery device for delivering an active substance to a patient at a predetermined time after administration comprises a male hydrogel plug engaged in the neck of a female body. An expandable...
5891456 Glyceryl monosterate based biodegradable implants for site-specific delivery of drugs  
A method to administer a drug locally to a subject in which biodegradable dosage forms that contain the drug are implanted at a localized site beneath the skin of the subject whereupon the dosage...
5891458 Bioerodible device for administering active ingredients  
The invention relates to a muco-adherent, soluble device for administering active ingredients, a method of using said device, and an improved method of manufacturing said device using a continuous,...
5888528 Sustained release biocidal powders  
A powder for sustained release of a gas including a hydrophilic core, a hydrophobic layer on an outer surface of the hydrophilic core, and particles in contact with the hydrophobic layer. The...
5888534 Controlled release of drugs delivered by sublingual or buccal administration  
A composition providing a relatively slow release of water-soluble drugs, such as apomorphine, for delivery via the sublingual or buccal routes.
5885590 Oral vaccines comprising multiple emulsions and methods of preparation  
The present invention relates to water-in-oil and water-in-oil-in-water multiple emulsions and methods of preparation which overcome many of the limitations of previous emulsions and are superior...
5882689 Control of soilborne fungi in cultivated crops  
This invention provides a method for controlling soilborne fungal disease in cultivated field plants such as a peanut crop. Field crop soil is treated with a free-flowing granular fungicide...
5883045 Method for the treatment of plants with agrochemical tablet compositions  
Novel method for applying agrochemicals to plants, which method consists in attaching to the surface of the plants tablets comprising at least one agrochemically active compound and at least...
5879706 Valaciclovir tablets containing colloidal silicon dioxide  
A tablet comprising at least 50% w/w valaciclovir and 0.05 to 3% w/w colloidal silicon dioxide in which the valaciclovir is present within granules of the tablets and the silicon dioxide, a...
5879662 Oral echo contrast medium for ultrasonic diagnosis  
An oral contrast agent for use in ultrasound diagnostic procedures in human medicine to create an image of the gastrointestinal tract. The oral contrast agent contains at least one thickening agent...
5879688 Hydroxy-acid cosmetics  
A method for alleviating the symptoms of a cosmetic or dermatologic skin condition is described. An effective amount of a poly(hydroxy acid)/polymer conjugate in a pharmaceutically or cosmetically...
5869074 Pesticidal compositions  
The pesticidal composition of the invention comprises dichlorvos and chlorpyrifos. The composition is prepared by combining the components together and then subjecting the mixture to microwave...
5863555 Buccal delivery of glucagon-like insulinotropic peptides  
Drug delivery systems and methods for administering a glucagon-like insulinotropic peptide to the buccal mucosa for transmucosal drug delivery are described. The drug delivery systems comprise a...
5861172 Pharmaceutical formulations of compacted granulates of β-lactam antibiotics  
The present invention discloses tablet formulations, produced by dry roller compaction comprising compacted granulates of a mixture of a medicament and an intra-granular disintegrant. The...
5859069 Gelatinous external skin treatment composition  
A gelatinous external skin treatment composition comprising (1) spherical powder of organopolysiloxane elastomer having an average particle size of 1.0 to 15.0 μm, (2) silicone oil and (3)...
5858345 In vivo polymerizable ophthalmic compositions  
Ophthalmic compositions containing biocompatible, bioadhesive polymerizable amphipathic mesophase materials useful for repairing retinal tissue tears or retinal detachments are disclosed. In one...
5859161 Silicone phosphate esters as irritation mitigants  
The present invention relates to a series of novel silicone phosphate esters which mitigate eye and skin irritation when used in synergistic combinations with fatty alcohol sulfates and fatty...
5855900 Supramolecular-structured biodegradable polymeric assembly for drug delivery  
This invention provides as a novel drug carrier into a living body a highly water-soluble polymer that can carry and release a drug at a desired rate and a supramolecular-structured biodegradable...
5851277 Preparation whose coloring depends on the viewing angle  
The invention relates to cosmetic or pharmaceutical preparations comprising pigments whose coloring depends on the viewing angle and comprising additives which are customary for cosmetic or...
5849266 Dental composition for hypersensitive teeth  
The invention relates to an oral composition for the treatment and prevention of dental hypersensitivity comprising an anti-hypersensitivity agent embedded in a sustained release carrier such as a...
5846564 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection  
Effervescent composition comprising in synergetic quantities: iodinated polyvinylpyrrolidone (IPVP) at least one effervescent agent, and at least one disintegrating agent. It may be presented in...
5847023 Thermal irreversible gel corneal contact lens formed in situ  
Balanced pH, thermo-irreversible gels comprising a polyoxyalkylene compound and an ionic polysaccharide are ideal materials for the formation of a protective contact lens over the cornea of the eye...
5847046 Biodegradable bone cement  
A surgical bonding material includes a continuous phase and a discontinuous phase. The continuous phase is formed from a polymerizable liquid. The discontinuous phase includes particles of...
5840329 Pulsatile drug delivery system  
A pulsatile drug delivery system comprising of a plurality of particles is able to deliver drug in any desired patterns. A plurality of particles with multi-layer core capable of short-pulse...